Skip to main content
SpringerLink
Log in

Preoperative Staging

  • Chapter
Prostate Cancer

  • 144 Accesses

Abstract

The detection of prostate carcinoma is currently based on three parameters: digital rectal examination (DRE), serum prostate-specific antigen (PSA), and transrectal ultrasound of the prostate (TRUS) (although TRUS is mainly used as a guide for biopsies) [26,46]. Definitive treatment for localized prostate cancer is most effective when the cancer is organ-confined or specimen-confined at the time of treatment [57].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aarnink RG, Beerlage HP, De La Rosette JJ, Debruyne FM, Wijkstra H (1998) Transrectal ultrasound of the prostate: innovations and future applications. J Urol 159:15668–1579

    Article  Google Scholar 

  2. Albertsen PC, Hanley JA, Harlan LC, Gilliland FD, Hamilton A, Liff JA, Stanford JL, Stephenson RA. (2000) The positive yield of imaging studies in the evaluation of men with newly diagnosed prosatate cancer: a population based analysis. J Urol 163:1138–1143

    Article  PubMed  CAS  Google Scholar 

  3. Bartolozzi C, Menchi I, Lencioni R, et al (1996) Local staging of prostate carcinoma with endorectalcoil MRI. Correlation with whole mount radical prostatectomy specimens. Eur Radiol 6:339–345

    PubMed  CAS  Google Scholar 

  4. Bostwick DG, Iczkowiski KA. (1998) Microvessel density in prostate cancer: prognostic and therapeutic utility. Semin Urol Oncol 16:118–123

    PubMed  CAS  Google Scholar 

  5. Catalona WJ, Basler JW. (1993) Return of erections and urinary continence following nerve sparing radical prostatectomy. J Urol 150:905

    PubMed  CAS  Google Scholar 

  6. Chan TY, Partin AW, Walsh PC, Epstein JI. (2000) Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatctomy [abstract]. J Urol 163 [Suppl 4]:1422

    Google Scholar 

  7. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM. (1993) Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 150:391–395

    PubMed  CAS  Google Scholar 

  8. Cho JY, Kim SH, Lee SE. (2000) Peripheral hypoechoic lesions of the prostate: evaluation with color and power doppler ultrasound. Eur Urol 37:443–448

    Article  PubMed  CAS  Google Scholar 

  9. Chybowski FM, Keller JJ, Bergstralh EJ, Oesterling JE. (1991) Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol 145:313–318

    PubMed  CAS  Google Scholar 

  10. Conrad S, Graefen M, Pichlmeier U, Hammerer P, Huland H (1998) Systematic sextant biopsies enhance the accuracy of predicting pelvic lymph node metatstasis in prostatic cancer. J Urol 159:2023

    Article  PubMed  CAS  Google Scholar 

  11. Cornud F, Hamida K, Flam T, Helenon O, Chretien Y, Thiounn N, Correas JM, Casanova JM, Moreau JF. (2000) Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol 175:1161–1168

    Article  PubMed  CAS  Google Scholar 

  12. D”Amico AV, Whittington R, Malkowicz SB, et al (1999) Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 17:168–172

    CAS  Google Scholar 

  13. de la Rosette JJ, Aarnink RG. (2001) New developments in ultrasonography for the detection of prostate cancer. J Endourol 15:93–104

    Article  PubMed  Google Scholar 

  14. Egawa S, Suyama K, Matsumoto K, Satoh T, Ucida T, Kuwao S, Koshiba K (1998) Improved predictibility of extracapsular extension and seminal vesical involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology 52:433

    Article  PubMed  CAS  Google Scholar 

  15. El-Gabry EA, Halpern EJ, Strup SE, Gomella LG. (2001) Imaging prostat cancer: current and future applications. Oncology 15: 325–336

    PubMed  CAS  Google Scholar 

  16. Engelbrecht MR, Barentsz JO, Jager GJ, van der Graaf M, Heerschap A, Sedelaar JP, Aarnink RG, de la Rosette JJ. (2000) Prostate cancer staging using imaging. BJU Int 86 [Suppl 1]:123–134

    Article  PubMed  Google Scholar 

  17. Garg S, Fortling B, Chadwick D, Robinson MC, Hamdy FC. (1999) Staging of prostate cancer using 3-dimensional transrectal ultrasound images: a pilot study. J Urol 162:1318–1321

    Article  PubMed  CAS  Google Scholar 

  18. Giesen RJ, Huynen AL, Aarnink RG, de la Rosette JJ, v d Kaa C, Oosterhof GO, Debruyne FM, Wijkstra H (1995) Computer analysis of transrectal ultrasound images of the prostate for the detection of carcinoma: a prospective study in radical prostatectomy specimens. J Urol 154: 1397–1400

    Article  PubMed  CAS  Google Scholar 

  19. Goto Y, Ohori M, Scardino PT. (1998) Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report. Int J Urol 5:337

    Article  PubMed  CAS  Google Scholar 

  20. Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R-P, Huland E, Huland H (1999) Early PSA relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol 36:21

    Article  PubMed  CAS  Google Scholar 

  21. Graefen M, Haese A, Pichlmeier U, Hammerer PG, Noldus J, Butz K, Erbersdobler A, Henke RP, Michl U, Fernandez S, Huland H (2001) A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol 165:857–863

    Article  PubMed  CAS  Google Scholar 

  22. Graefen M, Karakiewicz PI, Cagiannos I, Klein E, Kupelian PA, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Strieker PD, de Kernion J, Cangiano T, Schroder FH, Wildhagen MF, Scardino PT, Kattan MW. (2002) Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 20(4): 951–956

    Article  PubMed  Google Scholar 

  23. Hammerer P, Huland H, Sparenberg A (1992) Digital rectal examination, imaging, and random biopsies in identifying lymph-node-negative prostatic carcinoma. Eur Urol 22:281–286

    PubMed  CAS  Google Scholar 

  24. Hammerer P, Huland H (1994) Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 151:99–102

    PubMed  CAS  Google Scholar 

  25. Harrell FE, Califf RM. (1982) Evaluating the yield of medical tests. JAMA 247:2543–2546

    Article  PubMed  Google Scholar 

  26. Hodge KK, McNeal JE, Terris MK, Stamey TA. (1989) Random-systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74

    PubMed  CAS  Google Scholar 

  27. Horoszewicz JS, Kawinski E, Murphy GP. (1987) Monoclonal antibodies to a new antigenic markerin epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 7: 927–935

    PubMed  CAS  Google Scholar 

  28. Hricak H, White S, Vigneron DB, et al (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 193:703–709

    PubMed  CAS  Google Scholar 

  29. Huland H, Hübner D, Henke R-P. (1994) Systematic biopsies and digital rectal examination to identify the nerve-sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage T2, No prostatic carcinoma. Urology 44:211

    Article  PubMed  CAS  Google Scholar 

  30. Jager GJ, Barentsz JO, Oosterhof G, Witjes JA, Ruijs S.H.J. (1997) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional Ti-weighted magnetization-prepared rapid gradient-echo sequence. AJR Am J Roentgenol 167:1503–1507

    Article  Google Scholar 

  31. Kattan MW, Stapleton A.M.F, Wheeler TM, Scardino PT. (1997) Evaluation of a nomogram for predicting pathological stage of men with clinically localized prostate cancer. Cancer 79: 528–537

    Article  PubMed  CAS  Google Scholar 

  32. Kattan MW, Eastham JA, Stapleton A.M.F, Wheeler TM, Scardino PT. (1998) A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90:766–771

    Article  PubMed  CAS  Google Scholar 

  33. Klein EA, Zippe CD. (2000) Transrectal ultrasound guided prostate biopsy — defining a new standard [editorial]. J Urol 163:179

    Article  PubMed  CAS  Google Scholar 

  34. Lange PH. (2001) Prostascint scan for staging prostate cancer. Urology 57:402–406

    Article  PubMed  CAS  Google Scholar 

  35. Lavoipierre AM, Snow RM, Frydenberg M, Gunter D, Reisner G, Royce PL, Lavoipierre GJ. (1998) Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol 171:205–210

    Article  PubMed  CAS  Google Scholar 

  36. Lee F, Torp-Pedersen ST, Siders DB, Littrup PJ, McLeary RD. (1989) Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology 170:609–615

    PubMed  CAS  Google Scholar 

  37. Lee N, Fawaaz R, Olsson CA, Benson MC, Petrylak DP, Schiff PB, Bagiella E, Singh A, Ennis RD. (2000) Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients. Int J Radiat Oncol Biol Phys 48:1443–1446

    Article  PubMed  CAS  Google Scholar 

  38. Liu IJ, Zafar MB, Lai Y, Segall GM, Terris MK. (2001) Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology 57:108–111

    Article  PubMed  CAS  Google Scholar 

  39. Loch T, Leuschner I, Genberg C, Weichert-Jacobsen K, Kuppers F, Yfantis E, Evans M, Tsarev V, Stöckle M (1999) Artificial neural network analysis (ANNA) of prostatic transrectal ultrasound. Prostate 39:198–204

    Article  PubMed  CAS  Google Scholar 

  40. May F, Treumann T, Dettmar P, Hartung R, Breul J (2001) Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 87:66–69

    Article  PubMed  CAS  Google Scholar 

  41. Montie JE, Wei JT. (2000) Artificial neural networks for prostate carcinoma risk assessment: an overview. Cancer 88:2655–2660

    Article  PubMed  CAS  Google Scholar 

  42. Noldus J, Graefen M, Hammerer P, Henke R-P, Huland H (1998) Entwicklung der Tumorselektion anhand des pathologischen Stadiums beim klinisch lokalisierten Prostatakarzinom. Urologe A 37:195

    Article  PubMed  CAS  Google Scholar 

  43. Outwater E, Petersen RO, Siegelman ES, Gomella LG, Chernesky CE, Mitchell DG. (1994) Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 193:333–339

    PubMed  CAS  Google Scholar 

  44. Oyen RH, Van Poppel HP, Ameye FE, Van de Voorde WA, Baert AL, Baert LV. (1994) Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 190:315–322

    PubMed  CAS  Google Scholar 

  45. Partin AW, Yoo J, Ballentine Carter JY, et al (1993) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostatecancer. J Urol 150:110–115

    PubMed  CAS  Google Scholar 

  46. Partin AW, Kattan MW, Subong EN, et al (1997) Combination of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277:1445

    Article  PubMed  CAS  Google Scholar 

  47. Presti JC Jr, Hricak H, Narayan PA, Shinohara K, White S, Carroll PR. (1996) Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectl MR imaging. AJR Am J Roentgenol 166:103–108

    Article  PubMed  Google Scholar 

  48. Ragde H, Kenny GM, Murphy GP, Landin K (1997) Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate 32:279–283

    Article  PubMed  CAS  Google Scholar 

  49. Ronco AL, Fernandez R (1999) Improving ultrasonographic diagnosis of prostate cancer with neural networks. Ultrasound Med Biol 25:729–733

    Article  PubMed  CAS  Google Scholar 

  50. Rúrvik J, Halvorsen OJ, Albrektsen G, Ersland L, Daehlin L, Haukaas S (1999) MRI with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. Eur Radiol 9:29–34

    Article  Google Scholar 

  51. Sakarya ME, Arslan H, Unal O, Atilla MK, Aydin S (1998) The role of power Doppler ultrasonography in the diagnosis of prostate cancer: a preliminary study. Br J Urol 82:386–388

    Article  PubMed  CAS  Google Scholar 

  52. Schiebler ML, Schnall MD, Pollack HM, et al (1993) Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189:339–352

    PubMed  CAS  Google Scholar 

  53. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H (2000) The precent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 163:174

    Article  PubMed  CAS  Google Scholar 

  54. Sedelaar J.P.M, Aarnink R.G, van Leenders G.J.L.H, Beerlage HP, Debruyne F.M.J, Wijkstra H, de la Rosette J.J.M.C.H (2000) The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol 37:559–568

    Article  PubMed  CAS  Google Scholar 

  55. Snow PB, Smith DS, Catalona WJ. (1994) Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 1525:1923–1926

    Google Scholar 

  56. Sonnad SS, Langlotz CP, Schwartz JS. (2001) Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change. Acad Radiol 8:149–157

    Article  PubMed  CAS  Google Scholar 

  57. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. (1999) Biological determinants of cancer progression in men with prostate cancer. JAMA 15:1395

    Article  Google Scholar 

  58. Watanabe H, Igari D, Tanahasi Y, Harada K, Saito M (1974) Development and application of new equipment for transrectal ultrasonography. J Clin Ultrasound 2:91–98

    Article  PubMed  CAS  Google Scholar 

  59. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. (1990) Ultrasmall super-paramagnetic iron oxide: an intravenous contrast agent for assessing lymphnodes with MR imaging. Radiology 175:494–498

    PubMed  CAS  Google Scholar 

  60. White S, Hricak H, Forstner R, et al (1995) Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385–390

    PubMed  CAS  Google Scholar 

  61. Wills ML, Sauvageot J, Partin AW, Gurganus R, Epstein JI. (1998) Ability of sextant biopsies to predict radical prostatectomy stage. Urology 51:759

    Article  PubMed  CAS  Google Scholar 

  62. Yu KK, Hricak H, Alagappan R, Chernoff DM, Bacchetti P, Zaloudek CJ. (1997) Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 202:697–702

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. Hammerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Graefen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Haese
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Palisaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Noldus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Huland
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology and Pediatric Urology, Philipps Universität Marburg, Baldingerstrasse 3, 35043, Marburg/Lahn, Germany

    Reiner Hofmann  & Axel Heidenreich  & 

  2. Department of Surgery, USUHS, 430 I Jones Bridge Road, 20814-4799, Bethesda, MD, USA

    Judd W. Moul M.D. (Professor of Urology) (Professor of Urology)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hammerer, P. et al. (2003). Preoperative Staging. In: Hofmann, R., Heidenreich, A., Moul, J.W. (eds) Prostate Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56321-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56321-8_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62643-2

  • Online ISBN: 978-3-642-56321-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation